Global Relay Intelligence & Practice
All the latest news, insights, and publications from Global Relay.
Latest stories
We explore the compatibility of defense investments with responsible investing with Alex Miller, Danesmead Advisory.
Two FCA consultation papers prepare for implementation of an equities CT in the UK and aim to improve accessibility and clarity of trade data.
Our in-brief roundup of notable stories from the last week.
OpenAI provided the first detailed explanation of the Hugging Face incident at the annual cybersecurity conference in Las Vegas.
Highlights
Spotlight
Steve Penry on the evolution of energy market surveillance
Related articles
Industries Feed
Podcasts
Compliance
Mayr shares her story from math and economics to energy markets; and discusses the latest developments.
Case examines allegations involving AstraZeneca under the ABPI Code, underscoring the compliance controls drugmakers need to implement.
We assess how the guidance might influence a firm's response to an offensive social media post made by an employee in their private life.
The new unit will be staffed by attorneys and accountants with specialized skills related to financial reporting, accounting, and auditing.
Regulation
A new study found proposed Medicare drug pricing models may rely on prices from relatively few international markets.
Centers for Medicare & Medicaid Services moves to strengthen oversight of Applied Behavior Analysis services and reduce fraud, waste, and abuse.
HRSA health centers deliver ‘record-breaking’ care to 32.7 million patients
HRSA health centers are driving prevention first care, expanding access in underserved communities, and reinforcing accountability across the nation’s primary care system.
Justices rule drugmakers cannot be liable for delaying safer alternatives when existing products are FDA approved and nondefective.
Technology
Overview of EU AI Act transparency obligations under Art 50, and guidance for legal and compliance counsel.
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Our pick of the latest crypto stories.
Microsoft's Copilot was incorporated into memberships without customers' knowledge or consent.
Get full access, free for a month
Stay ahead with the compliance and regulatory insight you need. Start your 28-day free trial to access all content on GRIP – no payment details required.
What’s included:
- Every new article, plus our 5,000+ archive
- Daily regulatory insight and guidance
- Exclusive interviews and in-depth analysis
- Coverage of industry-leading events and conferences
- All podcasts and videos, featuring industry experts
- The full set of Rules Navigator tools
- An ad-free experience
Energy markets in the spotlight